THYROTOP 38-7400 MBq capsules for therapeutic use medication leaflet

V10XA01 sodium iodide (131I) • Various | Other therapeutic radiopharmaceuticals | Iodine (131i) compounds

Natrii iodidum (131I) is a radioactive compound used in the treatment and diagnosis of thyroid conditions such as hyperthyroidism and thyroid cancer. It emits radiation that destroys overactive or cancerous thyroid cells.

It is administered orally, in capsule or solution form, and is quickly absorbed by the thyroid gland. Treatment with Natrii iodidum (131I) is effective and minimally invasive, serving as an alternative to surgical interventions.

Side effects may include dry mouth, fatigue, or inflammation of the salivary glands. As a radioactive compound, its use requires special precautions to minimize radiation exposure.

Consult your doctor to discuss the benefits and risks of treatment with Natrii iodidum (131I). It is important to follow all instructions to ensure the safety and effectiveness of the treatment.

General data about THYROTOP 38-7400 MBq

Substance: sodium iodide (131I)

Date of last drug list: 01-06-2025

Commercial code: W62679003

Concentration: 38-7400MBq

Pharmaceutical form: capsules for therapeutic use

Quantity: 1

Product type: generic

Price: 847.54 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: INSTITUTE OF ISOTOPES CO. LTD.(IZOTOP INTEZET KFT) - UNGARIA

Holder: CN UNIFARM S.A. - ROMANIA

Number: 8806/2016/01

Shelf life: 21 de days de la data fabricatiei

Concentrations available for sodium iodide (131I)

0.333 MBq - 3.7 MBq, 0.37-3.7GBq, 0.37-36MBq, 14.8-3700MBq, 3.7MBq, 3.7MBq.1.85MBq.0.925MBq, 37-5500MBq, 37-7400MBq, 37MBq-5.55GBq, 38-7400MBq, 50- 7400MBq

Compensation lists for THYROTOP 38-7400 MBq UNIFARM

NHP 7 (C2) - Endocrine diseases

Price

Copayment

Patient

847.54 RON

847.54 RON

0.00 RON